JovaisasE., KochM.A., SchäferA.LAV/HTLV III in 20-week fetus. Lancet1985; 2: 1129.
4.
Di MariaH., CourpotinC., RouziouxC.Transplacental transmission of human immunodeficiency virus. Lancet1986; 1: 215–16.
5.
HarnishD.G., HammerbergO., WalkerI.R.Early detection of HlV infection in a newborn. N Engl J Med1987; 316: 272–73.
6.
LapointeN., MichandJ., PekovicD.Transplacental transmission of HTLV-III virus. N Engl J Med1985; 312: 1325–26.
7.
ThiryL., Sprecher-GoldbergerS., JonkheerT.Isolation of AlDS-virus from cell-free breast milk of three healthy virus carriers. Lancet1985; 2: 891–92.
8.
OgraP.L., OgraS.S.Cellular aspects of immunologic reactivity in human milk. In: HansonLÅ, ed. Biology of human milk. Nestlé Nutrition Workshop Series. vol. 15. New York: Raven Press, in press.
9.
ZieglerJ.B., CooperD.A., JohnsonR.O., GoldJ.Postnatal transmission of AlDS-associated retrovirus from mother to infant. Lancet1985; 1; 896–98.
10.
ChiodoF., RicchiE., CostigliolaP.Vertical transmission of HTLV-III. Lancet1986; 1: 739.
11.
Centers for Disease Control.Recommendations for assisting in the prevention of perinatal transmission of HTLV-III/LAV and acquired immunodeficiency syndrome. MMWR1985; 34(48). JAMA 1986; 255: 25-31.
12.
LucasA.AIDS and human milk bank closures. Lancet1987; 1: 1092–93.
13.
EglinR.P., WilkinsonA.R.HIV infection and pasteurization of breast milk. Lancet1987; 1: 1093.
14.
NorbergE.M.True disease pattern in East Africa. Parts 1 & II. E Afr Med J1983; 60(7/8): 446–52.